Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy R Martin

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 4, 2009
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and strokeMing Zhang, Billy R Martin, Martin W Adler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 11, 2009
Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoidsJohn R Grider, Sunila Mahavadi, Yan Li, et al.
Blood|July 2, 2002
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic diseaseRobert J McKallip, Catherine Lombard, Michael Fisher, et al.
Bioorganic & Medicinal Chemistry|November 14, 2006
Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogsF Ivy Carroll, Wei Ma, Hernán A Navarro, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanesF Ivy Carroll, Xingding Hu, Hernán A Navarro, et al.
Experimental and Clinical Psychopharmacology|August 11, 2004
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in ratsJenny L Wiley, Kari L LaVecchia, Natalie E Karp, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptorsR Bryan Rock, Genya Gekker, Shuxian Hu, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinolsJohn W Huffman, John R A Miller, John Liddle, et al.
British Journal of Pharmacology|March 22, 2005
CB1 cannabinoid receptor-mediated modulation of food intake in miceJenny L Wiley, James J Burston, Darnica C Leggett, et al.
Journal of the American Podiatric Medical Association|May 20, 2005
Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free daysDavid G Armstrong, Precious Salas, Brian Short, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 4, 2009
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and strokeMing Zhang, Billy R Martin, Martin W Adler, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 11, 2009
Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoidsJohn R Grider, Sunila Mahavadi, Yan Li, et al.
Blood|July 2, 2002
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic diseaseRobert J McKallip, Catherine Lombard, Michael Fisher, et al.
Bioorganic & Medicinal Chemistry|November 14, 2006
Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogsF Ivy Carroll, Wei Ma, Hernán A Navarro, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanesF Ivy Carroll, Xingding Hu, Hernán A Navarro, et al.
Experimental and Clinical Psychopharmacology|August 11, 2004
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in ratsJenny L Wiley, Kari L LaVecchia, Natalie E Karp, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptorsR Bryan Rock, Genya Gekker, Shuxian Hu, et al.
Bioorganic & Medicinal Chemistry|March 12, 2003
Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinolsJohn W Huffman, John R A Miller, John Liddle, et al.
British Journal of Pharmacology|March 22, 2005
CB1 cannabinoid receptor-mediated modulation of food intake in miceJenny L Wiley, James J Burston, Darnica C Leggett, et al.
Journal of the American Podiatric Medical Association|May 20, 2005
Maggot therapy in "lower-extremity hospice" wound care: fewer amputations and more antibiotic-free daysDavid G Armstrong, Precious Salas, Brian Short, et al.
Pageof 11